Harnessing the power of four scientific disciplines, Starpax Biopharma Inc., a biopharmaceutical research and development company, has conceived a revolutionary platform technology to treat cancer.

Previous Amounts Raised: $60 million
Founder: Michel Gareau
Year Founded: 2017

Reg A+ offering made available through Starpax Biopharma. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. Please see the most recent Offering Circular for more information.

Benzinga may receive monetary compensation from the issuer, or its agency, for publicizing the offering of the issuer’s securities. This content is for informational purposes only and is not intended to be investing advice. This is a paid ad.